Alexander Tepper

580 total citations
6 papers, 268 citations indexed

About

Alexander Tepper is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Alexander Tepper has authored 6 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Hematology. Recurrent topics in Alexander Tepper's work include CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and Protein Degradation and Inhibitors (2 papers). Alexander Tepper is often cited by papers focused on CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and Protein Degradation and Inhibitors (2 papers). Alexander Tepper collaborates with scholars based in United States and India. Alexander Tepper's co-authors include Taeyoon Kyung, Amanda A. Bouffard, Maria L. Cabral, Adam S. Sperling, Andrew A. Guirguis, Max Jan, Jessica A. Gasser, Andrea Schmidts, Michael C. Kann and Ana P. Castaño and has published in prestigious journals such as Cell, Blood and Science Translational Medicine.

In The Last Decade

Alexander Tepper

6 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Tepper United States	5	170	122	71	59	48	6	268
Tianning Gu China	9	166 1.0×	119 1.0×	46 0.6×	66 1.1×	47 1.0×	14	266
Katherine A. Freitas United States	2	179 1.1×	140 1.1×	43 0.6×	116 2.0×	34 0.7×	4	267
Tracy E. Garrett United States	8	275 1.6×	212 1.7×	92 1.3×	109 1.8×	58 1.2×	10	403
Atharva Karulkar India	7	151 0.9×	72 0.6×	56 0.8×	72 1.2×	51 1.1×	12	221
Rubí M.-H. Velasco Cárdenas Germany	5	184 1.1×	87 0.7×	68 1.0×	110 1.9×	36 0.8×	7	263
Gunjan Dagar India	8	156 0.9×	129 1.1×	45 0.6×	64 1.1×	37 0.8×	16	283
Nicholas F. Kuhn United States	6	217 1.3×	101 0.8×	60 0.8×	163 2.8×	57 1.2×	6	314
Ziran Zhao United States	6	131 0.8×	151 1.2×	39 0.5×	38 0.6×	29 0.6×	9	227
Alexandria Van Scoyk United States	7	146 0.9×	100 0.8×	29 0.4×	93 1.6×	39 0.8×	8	249
Tonia Nesheiwat United States	9	153 0.9×	110 0.9×	28 0.4×	37 0.6×	17 0.4×	22	195

Countries citing papers authored by Alexander Tepper

Since Specialization

Citations

This map shows the geographic impact of Alexander Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Tepper more than expected).

Fields of papers citing papers by Alexander Tepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Tepper. The network helps show where Alexander Tepper may publish in the future.

Co-authorship network of co-authors of Alexander Tepper

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Tepper. A scholar is included among the top collaborators of Alexander Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Tepper. Alexander Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mollaoglu, Gürkan, Alexander Tepper, Chiara Falcomatà, et al.. (2024). Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 187(26). 7492–7510.e22. 33 indexed citations

2.

Kann, Michael C., Emily M. Schneider, Amanda A. Bouffard, et al.. (2023). Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7. Leukemia. 38(3). 590–600. 4 indexed citations

3.

Jan, Max, Irene Scarfò, Rebecca C. Larson, et al.. (2021). Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Science Translational Medicine. 13(575). 180 indexed citations

4.

Chorzalska, Anna, Nagib Ahsan, R. Shyama Prasad Rao, et al.. (2018). Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia. Molecular Oncology. 12(5). 630–647. 32 indexed citations

5.

Chorzalska, Anna, Nagib Ahsan, Alexander Tepper, et al.. (2017). Map3k8/COT1/Tpl2 Drives Resistance to Bcr-Abl1 Inhibition through Activation of MEK-ERK and NF-Kb Pathways. Blood. 130. 2529–2529. 1 indexed citations

6.

Chorzalska, Anna, Karim Roder, Alexander Tepper, et al.. (2017). Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells and Development. 26(9). 656–677. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact